Ken Griffin Valneva Se Call Options Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
15Shares Held
663KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.3 Million0.18% of portfolio
-
Wells Fargo & Company San Francisco, CA243KShares$1.58 Million0.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$162,6430.1% of portfolio
-
Morgan Stanley New York, NY5.2KShares$33,8260.0% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD4KShares$26,0000.01% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $449M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...